Effects small to moderate, but may be worth prescribing to the motivated, say researchers ... Dec 23
Subcutaneous administration is preferred by patients, physicians and healthcare providers, and is associated with a reduction in healthcare costs ... Dec 23
The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain... Dec 23
The pharma company continues to plan for a mid-2021 launch of JZP-458 following completion of the BLA submission and US FDA review and ... Dec 23
The collaboration will help keep the manufacturing costs down and ensure long-term flexibility to meet future demand for years to come... Dec 23
-Advertisements-
.jpeg)
Friday, November 22, 2024
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)